Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease.
Overview
Abstract
Dementia is a syndrome caused by various diseases including Alzheimer's disease (AD) and frontotemporal dementia (FTD) with an estimated global prevalence of 60 million individuals. Recently, therapeutic development in the dementia field has accelerated, with the introduction of monoclonal antibody therapeutics such as Lecanemab and Donanemab. However, AD and FTD patients are still either diagnosed too late to benefit from available therapies or are misdiagnosed due to the clinical overlap between dementia subgroups making therapeutic intervention challenging. This highlights a real need to improve early diagnostic tools of neurodegenerative disease (ND) biomarkers. A potential source of such biomarkers come from small extracellular vesicles (sEVs), groups of cell-derived, lipid-bound assemblies with the capability to cross the blood–brain barrier (BBB) and known to carry pathogenic proteins associated with AD and FTD. A known cargo of sEVs is microRNA (miRNA), regulatory molecules that post-transcriptionally silence gene expression including transcripts of autophagic systems, processes which dysfunction in dementia-causing diseases leading to toxic aggregate build-up, causing neurodegeneration. The targeting of functional machineries in macroautophagy (MA) and chaperone-mediated autophagy (CMA) by different miRNA may vary between AD and FTD mutations, leading to potential biomarkers of disease being highlighted. Through isolating sEVs from the frontal cortex of post-mortem brain tissue of AD, FTD-MAPT, FTD-C9orf72, FTD-GRN and no-disease control patients (Manchester Brain Bank), miRNA cargoes were analysed and compared using real-time quantitative PCR (RT-qPCR). Seven autophagy-associated miRNA candidates (MA: miR-124-3p, miR-30a-5p, miR-128-3p; and CMA: miR-224-5p, miR-373-5p, miR-106a-3p and miR-26b-5p) were tested to identify dementia sub-group variations, used alongside small RNA-sequencing to explore broader miRNA variation within sEV populations. Of the miRNA tested miR-224-5p (P = 1.76 × 10−5) and miR-106a-3p (P = 0.033) showed significant group differences, and further significant pairwise comparison differences [miR-224-5p: AD fold change (FC) = 4.29, MAPT FC = 7.62; miR-106a-5p: AD FC = 5.59] when compared with no disease controls and other dementia subgroups, potentially showing initial diagnostic and differentiating potential. Small RNA-sequencing results revealed 8 AD, 2 FTD-GRN, 52 FTD-MAPT and 12 FTD-C9orf72 differentially expressed sEV-miRNAs when compared with no disease controls. Further direct comparisons between AD versus FTD mutation-derived sEV cargoes, and even FTD mutation versus FTD mutation-derived sEV cargoes, identified additional miRNA with differentiating capabilities. These findings demonstrate sEV-derived miRNA signatures vary across dementia sub-types and suggest potential roles of sEV cargoes in both disease diagnostics and identifying drivers of ND, such as autophagic impairments and signalling pathways.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data availability
The data supporting the findings of the current study are available from the corresponding author (G.L.) upon reasonable request. Additionally, code is available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 5 keywords, 1 funder, 60 references.
Cite
This paper
Morgan, J., Aarons, T., Mukhopadhyay, A., & Lace, G. (2026). Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease. Brain communications, 8(4), fcag277. https://
BibTeX
@article{morgan2026disti
author = {Morgan, Joseph and Aarons, Toby and Mukhopadhyay, Arijit and Lace, Gemma},
title = {{Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease}},
journal = {Brain communications},
year = {2026},
month = jul,
volume = {8},
number = {4},
pages = {fcag277},
publisher = {Oxford University Press},
issn = {2632-1297},
doi = {10.1093/
url = {https://
pmid = {42553702},
pmcid = {PMC13435624}
}
RIS
TY - JOUR
AU - Morgan, Joseph
AU - Aarons, Toby
AU - Mukhopadhyay, Arijit
AU - Lace, Gemma
TI - Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease
T2 - Brain communications
J2 - Brain Commun
PY - 2026
DA - 2026/
VL - 8
IS - 4
SP - fcag277
SN - 2632-1297
PB - Oxford University Press
DO - 10.1093/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1093/
"type": "article-journal",
"title": "Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease",
"container-title": "Brain communications",
"author": [
{
"family": "Morgan",
"given": "Joseph"
},
{
"family": "Aarons",
"given": "Toby"
},
{
"family": "Mukhopadhyay",
"given": "Arijit"
},
{
"family": "Lace",
"given": "Gemma"
}
],
"container-title-short":
"volume": "8",
"issue": "4",
"page": "fcag277",
"DOI": "10.1093/
"PMID": "42553702",
"PMCID": "PMC13435624",
"ISSN": "2632-1297",
"publisher": "Oxford University Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
21
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1002/jev2.70043 [code]
- Metabolic Profiling of Brain Tissue and Brain-Derived Extracellular Vesicles in Alzheimer's Disease.Journal: Journal of extracellular vesiclesIn common: Alzheimer's / dementia, cellular / molecular, 3 references
- [2] doi:10.1016/j.mcn.2025.104051
- AstroGreen transgenic mouse illuminates the trafficking of astrocyte-derived extracellular vesicles.Journal: Molecular and cellular neurosciencesIn common: cellular / molecular, 3 references
- [3] doi:10.1016/j.omta.2026.201757
- Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.Journal: Molecular therapy. AdvancesIn common: 3 references
- [4] doi:10.1186/s40478-023-01571-4
- Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.Journal: Acta neuropathologica communicationsIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [5] doi:10.1371/journal.ppat.1012733
- Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles directing astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain.Journal: PLoS pathogensIn common: cellular / molecular, 3 references
- [6] doi:10.3389/fnagi.2026.1788991
- Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia.Journal: Frontiers in aging neuroscienceIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [7] doi:10.1002/advs.202517862
- Intracellular Aβ42 Sequestration by a Serine Protease Mitigates Neurotoxicity in a Drosophila Alzheimer's Disease Model.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: Alzheimer's / dementia, cellular / molecular, 2 references
- [8] doi:10.1038/s42003-024-07182-6
- Mapping cellular stress and lipid dysregulation in Alzheimer-related progressive neurodegeneration using label-free Raman microscopy.Journal: Communications biologyIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [9] doi:10.1186/s13293-024-00588-1
- The role of microRNAs in understanding sex-based differences in Alzheimer's disease.Journal: Biology of sex differencesIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [10] doi:10.1016/j.celrep.2024.114061 [code]
- Human brain small extracellular vesicles contain selectively packaged, full-length mRNA.Journal: Cell reportsIn common: Alzheimer's / dementia, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
